Report Detail
Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3689013 |
- 22 August, 2019 |
- Global |
- 92 Pages |
- QYResearch |
- Pharma & Healthcare
Atherosclerosis is a disease in which the inside of an artery narrows due to the build up of plaque.
The identification of new drug targets for atherosclerosis will be one of the critical atherosclerosis therapeutics market trends driving the growth of the market. Although statins are regarded as the first line of treatment for decreasing LDL levels in the body, it exhibits secondary effects, such as hepatic enzyme elevation or muscular pain in some patients. Moreover, statins do not decrease the risk of cardiovascular diseases completely and is not recommended for patients having diabetes. This has encouraged researchers to focus on the evaluation of new drug targets, including triglyceride-rich particle metabolism regulators, proteins involved in glycoprotein recognition and clearance, and inflammatory pathways that affect efferocytosis. For instance, new proatherosclerotic pathways, such as lipoprotein A (LPA) and PCSK9 can significantly minimize the risk of atherosclerosis. PCSK9 inhibitors exhibit high therapeutic efficacy in reducing atherogenesis and do not increase the incidence of type 2 diabetes. Although more clinical trials are required for their use among atherosclerosis patients, continuous R&D in this field will positively impact the growth of the atherosclerosis therapeutics market.
In 2018, the global Atherosclerosis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Atherosclerosis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Atherosclerosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
AstraZeneca Plc
Bayer AG
Merck & Co. Inc.
Novartis AG
Sanofi
...
Market segment by Type, the product can be split into
Small Molecules
Biologics
Market segment by Application, split into
Hospital
Clinic
Research Institute
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Atherosclerosis Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Atherosclerosis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Atherosclerosis Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Atherosclerosis Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Small Molecules
- 1.4.3 Biologics
- 1.5 Market by Application
- 1.5.1 Global Atherosclerosis Therapeutics Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Research Institute
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Atherosclerosis Therapeutics Market Size
- 2.2 Atherosclerosis Therapeutics Growth Trends by Regions
- 2.2.1 Atherosclerosis Therapeutics Market Size by Regions (2019-2025)
- 2.2.2 Atherosclerosis Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Atherosclerosis Therapeutics Market Size by by Players
- 3.1.1 Global Atherosclerosis Therapeutics Revenue by by Players (2014-2019)
- 3.1.2 Global Atherosclerosis Therapeutics Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Atherosclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Atherosclerosis Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Atherosclerosis Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Atherosclerosis Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Atherosclerosis Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Atherosclerosis Therapeutics Market Size by Application (2014-2019)
5 North America
- 5.1 North America Atherosclerosis Therapeutics Market Size (2014-2019)
- 5.2 Atherosclerosis Therapeutics Key Players in North America
- 5.3 North America Atherosclerosis Therapeutics Market Size by Type
- 5.4 North America Atherosclerosis Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Atherosclerosis Therapeutics Market Size (2014-2019)
- 6.2 Atherosclerosis Therapeutics Key Players in Europe
- 6.3 Europe Atherosclerosis Therapeutics Market Size by Type
- 6.4 Europe Atherosclerosis Therapeutics Market Size by Application
7 China
- 7.1 China Atherosclerosis Therapeutics Market Size (2014-2019)
- 7.2 Atherosclerosis Therapeutics Key Players in China
- 7.3 China Atherosclerosis Therapeutics Market Size by Type
- 7.4 China Atherosclerosis Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Atherosclerosis Therapeutics Market Size (2014-2019)
- 8.2 Atherosclerosis Therapeutics Key Players in Japan
- 8.3 Japan Atherosclerosis Therapeutics Market Size by Type
- 8.4 Japan Atherosclerosis Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Atherosclerosis Therapeutics Market Size (2014-2019)
- 9.2 Atherosclerosis Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Atherosclerosis Therapeutics Market Size by Type
- 9.4 Southeast Asia Atherosclerosis Therapeutics Market Size by Application
10 India
- 10.1 India Atherosclerosis Therapeutics Market Size (2014-2019)
- 10.2 Atherosclerosis Therapeutics Key Players in India
- 10.3 India Atherosclerosis Therapeutics Market Size by Type
- 10.4 India Atherosclerosis Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Atherosclerosis Therapeutics Market Size (2014-2019)
- 11.2 Atherosclerosis Therapeutics Key Players in Central & South America
- 11.3 Central & South America Atherosclerosis Therapeutics Market Size by Type
- 11.4 Central & South America Atherosclerosis Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 AstraZeneca Plc
- 12.1.1 AstraZeneca Plc Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Atherosclerosis Therapeutics Introduction
- 12.1.4 AstraZeneca Plc Revenue in Atherosclerosis Therapeutics Business (2014-2019))
- 12.1.5 AstraZeneca Plc Recent Development
- 12.2 Bayer AG
- 12.2.1 Bayer AG Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Atherosclerosis Therapeutics Introduction
- 12.2.4 Bayer AG Revenue in Atherosclerosis Therapeutics Business (2014-2019)
- 12.2.5 Bayer AG Recent Development
- 12.3 Merck & Co. Inc.
- 12.3.1 Merck & Co. Inc. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Atherosclerosis Therapeutics Introduction
- 12.3.4 Merck & Co. Inc. Revenue in Atherosclerosis Therapeutics Business (2014-2019)
- 12.3.5 Merck & Co. Inc. Recent Development
- 12.4 Novartis AG
- 12.4.1 Novartis AG Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Atherosclerosis Therapeutics Introduction
- 12.4.4 Novartis AG Revenue in Atherosclerosis Therapeutics Business (2014-2019)
- 12.4.5 Novartis AG Recent Development
- 12.5 Sanofi
- 12.5.1 Sanofi Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Atherosclerosis Therapeutics Introduction
- 12.5.4 Sanofi Revenue in Atherosclerosis Therapeutics Business (2014-2019)
- 12.5.5 Sanofi Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Atherosclerosis Therapeutics. Industry analysis & Market Report on Atherosclerosis Therapeutics is a syndicated market report, published as Global Atherosclerosis Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Atherosclerosis Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
